Perseus Proteomics (TSE:4882) EBIT per Share : 円-77.39 (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Perseus Proteomics EBIT per Share?

Perseus Proteomics's EBIT per Share for the three months ended in Dec. 2023 was 円-20.73. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円-77.39.

During the past 3 years, the average EBIT per Share Growth Rate was 12.70% per year. During the past 5 years, the average EBIT per Share Growth Rate was -27.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Perseus Proteomics's EBIT per Share or its related term are showing as below:

TSE:4882' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -47.8 Med: -39.3 Max: 12.7
Current: 12.7

During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of Perseus Proteomics was 12.70% per year. The lowest was -47.80% per year. And the median was -39.30% per year.

TSE:4882's 3-Year EBIT Growth Rate is ranked better than
57.26% of 861 companies
in the Drug Manufacturers industry
Industry Median: 7.4 vs TSE:4882: 12.70

Perseus Proteomics's EBIT for the three months ended in Dec. 2023 was 円-245.25 Mil.

Perseus Proteomics EBIT per Share Historical Data

The historical data trend for Perseus Proteomics's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perseus Proteomics EBIT per Share Chart

Perseus Proteomics Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EBIT per Share

Get a 7-Day Free Trial

-15.89

-89.12

-58.82

-42.94

-59.34

Perseus Proteomics Quarterly Data
	Mar18	Mar19	Dec19	Mar20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT per Share	Get a 7-Day Free Trial												-14.38	-18.88	-19.95	-17.83	-20.73

Perseus Proteomics EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Perseus Proteomics's EBIT per Share for the fiscal year that ended in Mar. 2023 is calculated as

	EBIT per Share		(A: Mar. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-697.77	/	11.759
=	-59.34

Perseus Proteomics's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-245.245	/	11.830
=	-20.73

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-77.39

Perseus Proteomics (TSE:4882) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Perseus Proteomics EBIT per Share Related Terms

Thank you for viewing the detailed overview of Perseus Proteomics's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Perseus Proteomics (TSE:4882) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perseus Proteomics Inc (TSE:4882) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

4-7-6, Komaba, Tokyo Park Building, Meguro-ku, Tokyo, JPN, 153-0041

Website

https://www.ppmx.com

Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody based therapeutics and diagnostics drugs to cure against cancer and other diseases.

Perseus Proteomics (TSE:4882) Headlines

No Headlines